JPWO2021118629A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021118629A5 JPWO2021118629A5 JP2022535123A JP2022535123A JPWO2021118629A5 JP WO2021118629 A5 JPWO2021118629 A5 JP WO2021118629A5 JP 2022535123 A JP2022535123 A JP 2022535123A JP 2022535123 A JP2022535123 A JP 2022535123A JP WO2021118629 A5 JPWO2021118629 A5 JP WO2021118629A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidine
- dione
- oxoisoindolin
- methyl
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025015907A JP2025081364A (ja) | 2019-12-12 | 2025-02-03 | エストロゲン受容体分解活性を有する新規クロマン誘導体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962947213P | 2019-12-12 | 2019-12-12 | |
| US62/947,213 | 2019-12-12 | ||
| PCT/US2020/027895 WO2021118629A1 (en) | 2019-12-12 | 2020-04-13 | Novel chroman derivatives having estrogen receptor degradation activity and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015907A Division JP2025081364A (ja) | 2019-12-12 | 2025-02-03 | エストロゲン受容体分解活性を有する新規クロマン誘導体およびその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023506155A JP2023506155A (ja) | 2023-02-15 |
| JPWO2021118629A5 true JPWO2021118629A5 (https=) | 2024-01-29 |
| JP2023506155A5 JP2023506155A5 (https=) | 2024-01-29 |
| JP7662639B2 JP7662639B2 (ja) | 2025-04-15 |
Family
ID=70289288
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535123A Active JP7662639B2 (ja) | 2019-12-12 | 2020-04-13 | エストロゲン受容体分解活性を有する新規クロマン誘導体およびその使用 |
| JP2025015907A Pending JP2025081364A (ja) | 2019-12-12 | 2025-02-03 | エストロゲン受容体分解活性を有する新規クロマン誘導体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015907A Pending JP2025081364A (ja) | 2019-12-12 | 2025-02-03 | エストロゲン受容体分解活性を有する新規クロマン誘導体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10800770B1 (https=) |
| EP (2) | EP3835298B1 (https=) |
| JP (2) | JP7662639B2 (https=) |
| KR (1) | KR102942706B1 (https=) |
| CN (2) | CN115003295B (https=) |
| CA (1) | CA3164202A1 (https=) |
| DK (1) | DK3835298T3 (https=) |
| ES (1) | ES2986594T3 (https=) |
| FI (1) | FI3835298T3 (https=) |
| MX (1) | MX2022007155A (https=) |
| WO (1) | WO2021118629A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102674902B1 (ko) | 2016-12-01 | 2024-06-14 | 아비나스 오퍼레이션스, 인코포레이티드 | 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 및 테트라히드로이소퀴놀린 유도체 |
| EP3932922A4 (en) | 2019-02-25 | 2022-05-11 | ShanghaiTech University | SULPHUR-CONTAINING COMPOUND BASED ON A GLUTARIMIDE FRAMEWORK AND ITS USE |
| WO2021023233A1 (zh) | 2019-08-05 | 2021-02-11 | 上海科技大学 | Egfr蛋白降解剂及其抗肿瘤应用 |
| IL320609A (en) | 2019-08-26 | 2025-07-01 | Arvinas Operations Inc | Methods for treating breast cancer with a history of tetrahydronaphthalene as estrogen receptor-disrupting agents |
| FI3835298T3 (fi) * | 2019-12-12 | 2024-07-29 | Accutar Biotechnology Inc | Uusia kromaanijohdannaisia, joilla on estrogeenireseptoria hajottava vaikutus, ja niiden käyttötapoja |
| WO2021133886A1 (en) * | 2019-12-23 | 2021-07-01 | Accutar Biotechnology | Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer |
| CA3169011A1 (en) * | 2020-02-25 | 2021-09-02 | Xiaobao Yang | Glutarimide skeleton-based compounds and uses thereof |
| AR123492A1 (es) | 2020-09-14 | 2022-12-07 | Arvinas Operations Inc | Formas cristalinas y amorfas de un compuesto para la degradación dirigida del receptor de estrógeno |
| EP4289841A4 (en) * | 2021-02-04 | 2025-02-19 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Benzo seven-membered ring bifunctional compound and application thereof |
| WO2022187588A1 (en) * | 2021-03-04 | 2022-09-09 | The Regents Of The University Of Michigan | Small molecule degraders of estrogen receptor with cereblon ligands |
| MX2023011166A (es) * | 2021-03-29 | 2023-09-29 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Compuesto de tetrahidronaftaleno, metodo de preparacion y uso del mismo en medicina. |
| EP4377296A1 (en) | 2021-07-26 | 2024-06-05 | Arvinas Operations, Inc. | Methods of manufacturing a bifunctional compound |
| AU2022370021B2 (en) * | 2021-10-22 | 2026-04-16 | Gluetacs Therapeutics (Shanghai) Co., Ltd. | Crbn e3 ligase ligand compound, protein degrading agent developed on the basis of ligand compound, and their applications |
| CN113816927B (zh) * | 2021-11-23 | 2022-02-25 | 苏州国匡医药科技有限公司 | 一种arv-471中间体的制备方法 |
| CN117229286A (zh) | 2022-06-14 | 2023-12-15 | 海创药业股份有限公司 | 一种芳香类化合物及其制备方法及在制备雌激素受体降解剂中的用途 |
| WO2024015409A1 (en) * | 2022-07-12 | 2024-01-18 | Regents Of The University Of Michigan | Chroman derivatives as estrogen receptor degraders |
| CN116751186B (zh) * | 2022-12-23 | 2024-10-18 | 南京知和医药科技有限公司 | 一种雌激素受体调节剂的制备及其用途 |
| WO2024153025A1 (zh) * | 2023-01-16 | 2024-07-25 | 南京明德新药研发有限公司 | 取代的苯并七元环化合物及其应用 |
| CN119258223A (zh) * | 2023-07-06 | 2025-01-07 | 海创药业股份有限公司 | 一种降解雌激素受体的联合用药物及其用途 |
| WO2025245408A1 (en) | 2024-05-22 | 2025-11-27 | Accutar Biotechnology Inc. | Chroman-based compounds for treating cancer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010021710A1 (en) * | 1996-10-28 | 2001-09-13 | Poul Jacobsen | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| IL129627A0 (en) | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| IL129618A0 (en) | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| EP1192945A3 (en) | 2000-09-21 | 2004-03-03 | Pfizer Products Inc. | Use of an estrogen agonist/antagonist for treating osteoarthritis |
| EP1465619A1 (en) | 2002-01-14 | 2004-10-13 | Nordic Bioscience A/S | Suppression of cartilage degradation via the estrogen receptor |
| WO2003063659A1 (de) | 2002-02-01 | 2003-08-07 | Danny Bellens | Ablageständer |
| CA2512000C (en) | 2002-12-26 | 2011-08-09 | Eisai Co., Ltd. | Selective estrogen receptor modulator |
| EP2536706B1 (en) | 2010-02-11 | 2017-06-14 | Celgene Corporation | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| EP3303326B1 (en) * | 2015-05-26 | 2020-12-16 | H. Hoffnabb-La Roche Ag | Heterocyclic estrogen receptor modulators and uses thereof |
| HK1257296A1 (zh) * | 2016-07-12 | 2019-10-18 | Accutar Biotechnology Inc. | 新的化合物及其用途 |
| KR102674902B1 (ko) * | 2016-12-01 | 2024-06-14 | 아비나스 오퍼레이션스, 인코포레이티드 | 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 및 테트라히드로이소퀴놀린 유도체 |
| FI3835298T3 (fi) * | 2019-12-12 | 2024-07-29 | Accutar Biotechnology Inc | Uusia kromaanijohdannaisia, joilla on estrogeenireseptoria hajottava vaikutus, ja niiden käyttötapoja |
-
2020
- 2020-04-13 FI FIEP20169240.7T patent/FI3835298T3/fi active
- 2020-04-13 WO PCT/US2020/027895 patent/WO2021118629A1/en not_active Ceased
- 2020-04-13 US US16/846,492 patent/US10800770B1/en active Active
- 2020-04-13 MX MX2022007155A patent/MX2022007155A/es unknown
- 2020-04-13 EP EP20169240.7A patent/EP3835298B1/en active Active
- 2020-04-13 CN CN202080092528.XA patent/CN115003295B/zh active Active
- 2020-04-13 ES ES20169240T patent/ES2986594T3/es active Active
- 2020-04-13 DK DK20169240.7T patent/DK3835298T3/da active
- 2020-04-13 KR KR1020227023616A patent/KR102942706B1/ko active Active
- 2020-04-13 JP JP2022535123A patent/JP7662639B2/ja active Active
- 2020-04-13 CN CN202510495956.1A patent/CN120665056A/zh active Pending
- 2020-04-13 EP EP24170522.7A patent/EP4420728A3/en active Pending
- 2020-04-13 CA CA3164202A patent/CA3164202A1/en active Pending
- 2020-06-22 US US16/907,548 patent/US11261178B2/en active Active
-
2025
- 2025-02-03 JP JP2025015907A patent/JP2025081364A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021118629A5 (https=) | ||
| JP7662639B2 (ja) | エストロゲン受容体分解活性を有する新規クロマン誘導体およびその使用 | |
| CN1129581C (zh) | 氰基苯基衍生物 | |
| EP2447253B1 (en) | Dihydropyrimidine compounds, preparation methods, pharmaceutical compositions thereof and their use as antiviral agents | |
| CA2777671C (en) | (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis | |
| JP2010531345A5 (https=) | ||
| JP6413032B2 (ja) | 新規ｄｇａｔ２阻害剤 | |
| JP2007509852A5 (https=) | ||
| RU2009119290A (ru) | Производные гидантоина, используемые в качестве ингибиторов ммр | |
| US8198305B2 (en) | 1,2-benzisoxazol-3-yl compounds | |
| US4367335A (en) | Thiazolidinylalkylene piperazine derivatives | |
| JP2004203871A (ja) | 医薬組成物 | |
| BR112013019942B1 (pt) | Uso de composto ou de seu sal farmaceuticamente aceitável, composição farmacêutica, compostos ou seus sais farmaceuticamente aceitáveis e respectivos processos de preparação | |
| TW201625597A (zh) | 囊性纖維化跨膜傳導調節蛋白之環丙烷甲醯胺調節劑 | |
| JPWO2003026661A1 (ja) | インスリン分泌促進剤及び新規なピリミジン誘導体 | |
| IL286902B1 (en) | Pyrrole compounds | |
| JPWO2020132014A5 (https=) | ||
| NL1028193C2 (nl) | Farmaceutisch werkzame verbindingen. | |
| CN1889940A (zh) | 热潮红、冲动控制障碍和全身性医学病症引起的人格变化的治疗 | |
| RU2009136246A (ru) | Новые соединения 707 и их применение | |
| BG110058A (bg) | Арипипразолови соли | |
| CN1166623C (zh) | 2-苯氧基苯胺类衍生物 | |
| JP7390487B2 (ja) | 焦点接着キナーゼ阻害剤としての新規なアダマンタン誘導体 | |
| TW495508B (en) | Amino acid ester containing azole antifungals | |
| PL207487B1 (pl) | Pochodna aminobenzofenonu o wzorze I, jej zastosowanie i kompozycja zawierająca ten związek |